Annual Working Capital
$40.45 M
-$20.63 M-33.77%
31 December 2023
Summary:
Longboard Pharmaceuticals annual working capital is currently $40.45 million, with the most recent change of -$20.63 million (-33.77%) on 31 December 2023. During the last 3 years, it has fallen by -$11.78 million (-22.56%). LBPH annual working capital is now -60.71% below its all-time high of $102.94 million, reached on 31 December 2021.LBPH Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$274.68 M
-$19.39 M-6.59%
30 September 2024
Summary:
Longboard Pharmaceuticals quarterly working capital is currently $274.68 million, with the most recent change of -$19.39 million (-6.59%) on 30 September 2024. Over the past year, it has increased by +$223.07 million (+432.21%). LBPH quarterly working capital is now -12.29% below its all-time high of $313.15 million, reached on 31 March 2024.LBPH Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LBPH Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.8% | +432.2% |
| 3 y3 years | -22.6% | +146.8% |
| 5 y5 years | - | - |
LBPH Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.7% | at low | -12.3% | +579.1% |
| 5 y | 5 years | -60.7% | at low | -12.3% | +579.1% |
| alltime | all time | -60.7% | at low | -12.3% | +579.1% |
Longboard Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $274.68 M(-6.6%) |
| June 2024 | - | $294.07 M(-6.1%) |
| Mar 2024 | - | $313.15 M(+674.2%) |
| Dec 2023 | $40.45 M(-33.8%) | $40.45 M(-21.6%) |
| Sept 2023 | - | $51.61 M(-10.5%) |
| June 2023 | - | $57.69 M(-19.6%) |
| Mar 2023 | - | $71.72 M(+17.4%) |
| Dec 2022 | $61.07 M | $61.07 M(-14.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $71.64 M(-13.3%) |
| June 2022 | - | $82.60 M(-11.6%) |
| Mar 2022 | - | $93.47 M(-9.2%) |
| Dec 2021 | $102.94 M(+97.1%) | $102.94 M(-7.5%) |
| Sept 2021 | - | $111.28 M(-5.2%) |
| June 2021 | - | $117.42 M(-1.8%) |
| Mar 2021 | - | $119.59 M(+129.0%) |
| Dec 2020 | $52.23 M | $52.23 M |
FAQ
- What is Longboard Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals annual working capital year-on-year change?
- What is Longboard Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals quarterly working capital year-on-year change?
What is Longboard Pharmaceuticals annual working capital?
The current annual working capital of LBPH is $40.45 M
What is the all time high annual working capital for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high annual working capital is $102.94 M
What is Longboard Pharmaceuticals annual working capital year-on-year change?
Over the past year, LBPH annual working capital has changed by -$20.63 M (-33.77%)
What is Longboard Pharmaceuticals quarterly working capital?
The current quarterly working capital of LBPH is $274.68 M
What is the all time high quarterly working capital for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high quarterly working capital is $313.15 M
What is Longboard Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, LBPH quarterly working capital has changed by +$223.07 M (+432.21%)